The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy.

Shao, Anqi; Owens, David M

Shao, Anqi; Owens, David M.

Afiliación

Shao A; Department of Dermatology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
Owens DM; Department of Dermatology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.

Oncotarget ; 14: 96-103, 2023 02 04.

Article en En | MEDLINE | ID: mdl-36738455

Asunto(s)

Neoplasias; Humanos; Inmunidad; Neoplasias/tratamiento farmacológico; Microambiente Tumoral

Palabras clave

CD200 receptor; immune checkpoint inhibition; immunotherapy; oncoimmunology; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Oncotarget Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google